AMY1B
MOLECULAR TARGETamylase alpha 1B
AMY1B (amylase alpha 1B) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting AMY1B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | scutellarein | 1.10 | 2 |
About AMY1B as a Drug Target
AMY1B (amylase alpha 1B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented AMY1B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
AMY1B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.